Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Option exercise Director acquired 2,010 shares (option exercise)
  2. 4 Option exercise Director acquired 8,107 shares (option exercise)
  3. 4 Option exercise Director acquired 8,107 shares (option exercise)
  4. 8-K Event Executive or director change · Shareholder vote results
  5. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 5,401 shares at $21.18 ($114,393)
  6. 144 Insider Sale of Securities
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,332 shares at $21.79 ($29,024)
  10. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,506 shares at $21.79 ($76,396)
  11. 8-K Event Executive or director change · Regulation FD disclosure
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. ARS Other Annual Report to Security Holders
  14. DEF 14A Proxy Proxy Statement
  15. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 2,709 shares at $22.20 ($60,140)
  16. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,030 shares at $22.20 ($22,866)
  17. 4 Open-market sale Chief Executive Officer sold 11,641 shares at $21.47 ($249,932)
  18. 4 Open-market sale EVP, Head of Research & Dev sold 3,435 shares at $21.47 ($73,749)
  19. 4 Open-market sale EVP, CHIEF LEGAL OFFICER, SEC sold 3,844 shares at $21.47 ($82,531)
  20. 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,942 shares at an average $21.57 ($41,895)

Page 2 of 70 · 1,382 filings